Registro:

Referencias:

• Ahmed, H., Banerjee, P.P., Vasta, G.R., Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation (2007) Biochem Biophys Res Commun., 358, pp. 241-246
• Balan, V., Nangia-Makker, P., Kho, D.H., Wang, Y., Raz, A., Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (Psa) cleavage (2012) J Biol Chem., 287, pp. 5192-5198
• Barthel, S.R., Gavino, J.D., Wiese, G.K., Jaynes, J.M., Siddiqui, J., Dimitroff, C.J., Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin (2008) Glycobiology, 18, pp. 806-817
• Brockhausen, I., Pathways of O-glycan biosynthesis in cancer cells (1999) Biochim Biophys Acta, 1473, pp. 67-95
• Brooks, S.A., Hall, D.M., Lectin histochemistry to detect altered glycosylation in cells and tissues (2012) Methods Mol Biol., 878, pp. 31-50
• Califice, S., Castronovo, V., Bracke, M., Van Den Brule, F., Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 (2004) Oncogene., 23, pp. 7527-7536
• Chauchereau, A., Experimental models for the development of new medical treatments in prostate cancer (2011) Eur J Cancer, 47, pp. S200-S214
• Clausse, N., Van Den Brule, F., Waltregny, D., Garnier, F., Castronovo, V., Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion (1999) Angiogenesis., 3, pp. 317-325
• Compagno, D., Jaworski, F.M., Gentilini, L., Contrufo, G., Gonzalez-Perez, I., Elola, M.T., Rabinovich, G.A., Laderach, D.J., Galectins: Major signaling modulators inside and outside the cell (2014) Curr Mol Med., , [Epub ahead of print]
• Compagno, D., Laderach, D.J., Gentilini, L., Jaworski, F.M., Rabinovich, G.A., Delineating the "galectin signature" of tumor microenvironment (2013) Oncoimmunology, 2
• Compagno, D., Merle, C., Morin, A., Gilbert, C., Mathieu, J., Bozec, A., Mauduit, C., Cabon, F., Sirna-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas (2007) PLoS ONE, 2
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Mendez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Toscano, M.A., Ouyang, J., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Domaica, C.I., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in kaposi's sarcoma (2012) J Exp Med., 209, pp. 1985-2000
• Cueni, L.N., Detmar, M., Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions (2009) Exp Cell Res., 315, pp. 1715-1723
• Dalziel, M., Crispin, M., Scanlan, C.N., Zitzmann, N., Dwek, R.A., Emerging principles for the therapeutic exploitation of glycosylation (2014) Science, 343
• Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Frahm, I., Rabinovich, G.A., Modulation of endothelial cell migration and angiogenesis: A novel function for the "Tandem-repeat" lectin galectin-8 (2011) FASEB J., 25, pp. 242-254
• Denmeade, S.R., Isaacs, J.T., A history of prostate cancer treatment (2002) Nat Rev Cancer, 2, pp. 389-396
• D'Haene, N., Sauvage, S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., Baum, L., Salmon, I., Vegfr1 and vegfr2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis (2013) PLoS ONE, 8
• Di Lella, S., Sundblad, V., Cerliani, J.P., Guardia, C.M., Estrin, D.A., Vasta, G.R., Rabinovich, G.A., When galectins recognize glycans: From biochemistry to physiology and back again (2011) Biochemistry, 50, pp. 7842-7857
• Dube, D.H., Bertozzi, C.R., Glycans in cancer and inflammation - Potential for therapeutics and diagnostics (2005) Nat Rev Drug Discov., 4, pp. 477-488
• Ellerhorst, J., Nguyen, T., Cooper, D.N., Lotan, D., Lotan, R., Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype (1999) Int J Oncol., 14, pp. 217-224
• Ellerhorst, J., Troncoso, P., Xu, X.C., Lee, J., Lotan, R., Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer (1999) Urol Res., 27, pp. 362-367
• Fry, S., Afrough, B., Leathem, A., Dwek, M., Lectin array-based strategies for identifying metastasis-associated changes in glycosylation (2012) Methods Mol Biol., 878, pp. 267-272
• Fukumori, T., Kanayama, H.-O., Raz, A., The role of galectin-3 in cancer drug resistance (2007) Drug Resist Updates, 10, pp. 101-108
• Fukushima, K., Satoh, T., Baba, S., Yamashita, K., Alpha1,2-fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer (2010) Glycobiology, 20, pp. 452-460
• Geney, R., Ungureanu, I.M., Li, D., Ojima, I., Overcoming multidrug resistance in taxane chemotherapy (2002) Clin Chem Lab Med., 40, pp. 918-925
• Gilgunn, S., Conroy, P.J., Saldova, R., Rudd, P.M., O'Kennedy, R.J., Aberrant psa glycosylation - A sweet predictor of prostate cancer (2013) Nat Rev Urol., 10, pp. 99-107
• Gleason, D.F., Histologic grade, clinical stage, and patient age in prostate cancer (1988) NCIMonogr., pp. 15-18
• Glinskii, O.V., Huxley, V.H., Glinsky, G.V., Pienta, K.J., Raz, A., Glinsky, V.V., Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs (2005) Neoplasia., 7, pp. 522-527
• Glinskii, O.V., Li, F., Wilson, L.S., Barnes, S., Rittenhouse-Olson, K., Barchi, J.J., Jr., Pienta, K.J., Glinsky, V.V., Endothelial integrin alpha3beta1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macro-molecular signaling complex formation at the endothelial cell membrane (2014) Oncotarget., 5, pp. 1382-1389
• Glinskii, O.V., Sud, S., Mossine, V.V., Mawhinney, T.P., Anthony, D.C., Glinsky, G.V., Pienta, K.J., Glinsky, V.V., Inhibition of prostate cancer bone metastasis by synthetic tf antigen mimic/Galectin-3 inhibitor lactulose-L-leucine (2012) Neoplasia., 14, pp. 65-73
• Glinsky, V.V., Glinsky, G.V., Rittenhouse-Olson, K., Huflejt, M.E., Glinskii, O.V., Deutscher, S.L., Quinn, T.P., The role of thomsen-friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium (2001) Cancer Res., 61, pp. 4851-4857
• Glinsky, V.V., Glinsky, G.V., Glinskii, O.V., Huxley, V.H., Turk, J.R., Mossine, V.V., Deutscher, S.L., Quinn, T.P., Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium (2003) Cancer Res., 63, pp. 3805-3811
• Glinsky, V.V., Kiriakova, G., Glinskii, O.V., Mossine, V.V., Mawhinney, T.P., Turk, J.R., Glinskii, A.B., Glinsky, G.V., Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo (2009) Neoplasia., 11, pp. 901-909
• Glinsky, G.V., Mossine, V.V., Price, J.E., Bielenberg, D., Glinsky, V.V., Ananthaswamy, H.N., Feather, M.S., Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs (1996) Clin Exp Metastasis, 14, pp. 253-267
• Grabowska, M.M., Degraff, D.J., Yu, X., Jin, R.J., Chen, Z., Borowsky, A.D., Matusik, R.J., Mouse models of prostate cancer: Picking the best model for the question (2014) Cancer Metastasis Rev., , PMID: 24452759. [Epub ahead of print]
• Guha, P., Kaptan, E., Bandyopadhyaya, G., Kaczanowska, S., Davila, E., Thompson, K., Martin, S.S., Ahmed, H., Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis (2013) Proc Natl Acad Sci USA, 110, pp. 5052-5057
• Hadari, Y.R., Arbel-Goren, R., Levy, Y., Amsterdam, A., Alon, R., Zakut, R., Zick, Y., Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis (2000) J Cell Sci., 113, pp. 2385-2397
• Hauselmann, I., Borsig, L., Altered tumor-cell glycosylation promotes metastasis (2014) Front Oncol., 4, p. 28
• He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab Invest., 86, pp. 578-590
• Heimburg, J., Yan, J., Morey, S., Glinskii, O.V., Huxley, V.H., Wild, L., Klick, R., Rittenhouse-Olson, K., Inhibition of spontaneous breast cancer metastasis by anti-thomsen-friedenreich antigen monoclonal antibody jaa-F11 (2006) Neoplasia., 8, pp. 939-948
• Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics (2011) CA Cancer J Clin., 61, pp. 69-90
• Johnson, K.D., Glinskii, O.V., Mossine, V.V., Turk, J.R., Mawhinney, T.P., Anthony, D.C., Henry, C.J., Pienta, K.J., Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia (2007) Neoplasia., 9, pp. 662-670
• Kamigaito, T., Okaneya, T., Kawakubo, M., Shimojo, H., Nishizawa, O., Nakayama, J., Overexpression of O-glcnac by prostate cancer cells is significantly associated with poor prognosis of patients (2014) Prostate Cancer Prostatic Dis., 17, pp. 18-22
• Knapp, J.S., Lokeshwar, S.D., Vogel, U., Hennenlotter, J., Schwentner, C., Kramer, M.W., Stenzl, A., Merseburger, A.S., Galectin-3 expression in prostate cancer and benign prostate tissues: Correlation with biochemical recurrence (2013) World J Urol., 31, pp. 351-358
• Laderach, D.J., Compagno, D., Toscano, M.A., Croci, D.O., Dergan-Dylon, S., Salatino, M., Rabinovich, G.A., Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings (2010) IUBMB Life, 62, pp. 1-13
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Mazza, O., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res., 73, pp. 86-96
• Lange, T., Ullrich, S., Muller, I., Nentwich, M.F., Stubke, K., Feldhaus, S., Knies, C., Abramjuk, C., Human prostate cancer in a clinically relevant xenograft mouse model: Identification of beta(1,6)-branched oligosaccharides as a marker of tumor progression (2012) Clin Cancer Res., 18, pp. 1364-1373
• Lee, S.H., Hatakeyama, S., Yu, S.Y., Bao, X., Ohyama, C., Khoo, K.H., Fukuda, M.N., Fukuda, M., Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma pc3 and lncap cells through down-regulation of alpha2beta1 integrin complex (2009) J Biol Chem., 284, pp. 17157-17169
• Lehr, J.E., Pienta, K.J., Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line (1998) J Natl Cancer Inst., 90, pp. 118-123
• Levy, Y., Arbel-Goren, R., Hadari, Y.R., Eshhar, S., Ronen, D., Elhanany, E., Geiger, B., Zick, Y., Galectin-8 functions as a matricellular modulator of cell adhesion (2001) J Biol Chem., 276, pp. 31285-31295
• Levy, Y., Ronen, D., Bershadsky, A.D., Zick, Y., Sustained induction of erk, protein kinase B, and P70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin (2003) J Biol Chem., 278, pp. 14533-14542
• Li, J., Guillebon, A.D., Hsu, J.W., Barthel, S.R., Dimitroff, C.J., Lee, Y.F., King, M.R., Human fucosyltransferase 6 enables prostate cancer metastasis to bone (2013) Br J Cancer, 109, pp. 3014-3022
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat Rev Cancer, 5, pp. 29-41
• Liu, X., Yang, P., Hart, G., O-glcnacylation modifies the metastatic properties of prostate cancer cells (2014) FASEB J., 28, pp. 789-795
• Lynch, T.P., Ferrer, C.M., Jackson, S.R., Shahriari, K.S., Vosseller, K., Reginato, M.J., Critical role of O-linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis (2012) J Biol Chem., 287, pp. 11070-11081
• Mariño, K., Bones, J., Kattla, J.J., Rudd, P.M., A systematic approach to protein glycosylation analysis: A path through the maze (2010) Nat Chem Biol., 6, pp. 713-723
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of Vegf- and Bfgf-mediated angiogenic response (2011) J Exp Med., 207, pp. 1981-1993
• Mechref, Y., Hu, Y., Garcia, A., Zhou, S., Desantos-Garcia, J.L., Hussein, A., Defining putative glycan cancer biomarkers by ms (2012) Bioanalysis., 4, pp. 2457-2469
• Merseburger, A.S., Kramer, M.W., Hennenlotter, J., Simon, P., Knapp, J., Hartmann, J.T., Stenzl, A., Kuczyk, M.A., Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer (2008) Prostate, 68, pp. 72-77
• Miller, V., Interpretation of resistance assay results (2001) Antivir Ther., 6, pp. 1-9
• Nangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., Raz, A., Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin (2002) J Natl Cancer Inst., 94, pp. 1854-1862
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Raz, A., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am J Pathol., 156, pp. 899-909
• Nangia-Makker, P., Wang, Y., Raz, T., Tait, L., Balan, V., Hogan, V., Raz, A., Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer (2010) Int J Cancer, 127, pp. 2530-2541
• Ohyama, C., Hosono, M., Nitta, K., Oh-Eda, M., Yoshikawa, K., Habuchi, T., Arai, Y., Fukuda, M., Carbohydrate structure and differential binding of prostate specific antigen to maackia amurensis lectin between prostate cancer and benign prostate hypertrophy (2004) Glycobiology, 14, pp. 671-679
• Okamoto, T., Yoneyama, M.S., Hatakeyama, S., Mori, K., Yamamoto, H., Koie, T., Saitoh, H., Fukuda, M., Core2 O-glycan-expressing prostate cancer cells are resistant to nk cell immunity (2013) Mol Med Rep., 7, pp. 359-364
• Packer, N.H., Von Der Lieth, C.W., Aoki-Kinoshita, K.F., Lebrilla, C.B., Paulson, J.C., Raman, R., Rudd, P., York, W.S., Frontiers in glycomics: Bioinformatics and biomarkers in disease. An nih white paper prepared from discussions by the focus groups at a workshop on the nih campus, bethesda, MD (September 11-13, 2006) (2008) Proteomics., 8, pp. 8-20
• Peracaula, R., Tabares, G., Royle, L., Harvey, D.J., Dwek, R.A., Rudd, P.M., De Llorens, R., Altered glycosylation pattern allows the distinction between prostate-specific antigen (Psa) from normal and tumor origins (2003) Glycobiology, 13, pp. 457-470
• Petrylak, D.P., The current role of chemotherapy in metastatic hormone-refractory prostate cancer (2005) Urology, 65, pp. 3-7. , discussion 7-8
• Petrylak, D.P., Tangen, C.M., Hussain, M.H., Lara, P.N., Jr., Jones, J.A., Taplin, M.E., Burch, P.A., Kohli, M., Docetaxel and estra-mustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer (2004) NEngl JMed., 351, pp. 1513-1520
• Pienta, K.J., Loberg, R., The "emigration, migration, and immigration" of prostate cancer (2005) Clin Prostate Cancer, 4, pp. 24-30
• Pienta, K.J., Naik, H., Akhtar, A., Yamazaki, K., Replogle, T.S., Lehr, J., Donat, T.L., Raz, A., Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin (1995) J Natl Cancer Inst., 87, pp. 348-353
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Rabinovich, G.A., Toscano, M.A., Turning "Sweet" on immunity: Galectin-glycan interactions in immune tolerance and inflammation (2009) Nat Rev Immunol., 9, pp. 338-352
• Roodman, G.D., Mechanisms of bone metastasis (2004) Discov Med., 4, pp. 144-148
• Saldova, R., Fan, Y., Fitzpatrick, J.M., Watson, R.W., Rudd, P.M., Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia (2011) Glycobiology, 21, pp. 195-205
• Saraswati, S., Block, A.S., Davidson, M.K., Rank, R.G., Mahadevan, M., Diekman, A.B., Galectin-3 is a substrate for prostate specific antigen (Psa) in human seminal plasma (2011) Prostate, 71, pp. 197-208
• Slovin, S.F., Ragupathi, G., Musselli, C., Olkiewicz, K., Verbel, D., Kuduk, S.D., Schwarz, J.B., Livingston, P.O., Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: Clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine (2003) J Clin Oncol., 21, pp. 4292-4298
• Su, Z.Z., Lin, J., Shen, R., Fisher, P.E., Goldstein, N.I., Fisher, P.B., Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene pcta-1 a member of the galectin gene family (1996) Proc Natl Acad Sci USA, 93, pp. 7252-7257
• Tannock, I.F., De Wit, R., Berry, W.R., Horti, J., Pluzanska, A., Chi, K.N., Oudard, S., Turesson, I., Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer (2004) N Engl J Med., 351, pp. 1502-1512
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Hackeng, T.M., Poirier, F., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70, pp. 6216-6224
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Bakkers, J., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci USA, 103, pp. 15975-15980
• Valenzuela, H.F., Pace, K.E., Cabrera, P.V., White, R., Porvari, K., Kaija, H., Vihko, P., Baum, L.G., O-glycosylation regulates lncap prostate cancer cell susceptibility to apoptosis induced by galectin-1 (2007) Cancer Res., 67, pp. 6155-6162
• Van Den Brule, F.A., Waltregny, D., Waltregny, D., Liu, F.T., Castronovo, V., Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression (2000) Int J Cancer, 89, pp. 361-367
• Van Kooyk, Y., Rabinovich, G.A., Protein-glycan interactions in the control of innate and adaptive immune responses (2008) Nat Immunol., 9, pp. 593-601
• Wang, Y., Balan, V., Gao, X., Reddy, P.G., Kho, D., Tait, L., Raz, A., The significance of galectin-3 as a new basal cell marker in prostate cancer (2013) Cell Death Dis., 4, p. e753
• Wang, Y., Nangia-Makker, P., Tait, L., Balan, V., Hogan, V., Pienta, K.J., Raz, A., Regulation of prostate cancer progression by galectin-3 (2009) Am J Pathol., 174, pp. 1515-1523
• Yin, X., Rana, K., Ponmudi, V., King, M.R., Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion (2010) Carbohydr Res., 345, pp. 2334-2342
• Yu, L.G., Andrews, N., Zhao, Q., McKean, D., Williams, J.F., Connor, L.J., Gerasimenko, O.V., Kasai, K., Galectin-3 interaction with thomsen-friedenreich disaccharide on cancer-associated muc1 causes increased cancer cell endothelial adhesion (2007) J Biol Chem., 282, pp. 773-781
• Zhao, Q., Barclay, M., Hilkens, J., Guo, X., Barrow, H., Rhodes, J.M., Yu, L.G., Interaction between circulating galectin-3 and cancer-associated muc1 enhances tumour cell homotypic aggregation and prevents anoikis (2010) Mol Cancer, 9, p. 154
• Zhuo, Y., Chammas, R., Bellis, S.L., Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis (2008) J Biol Chem., 283, pp. 22177-22185
• Zick, Y., Eisenstein, M., Goren, R.A., Hadari, Y.R., Levy, Y., Ronen, D., Role of galectin-8 as a modulator of cell adhesion and cell growth (2004) Glycoconj J., 19, pp. 517-526
• Zou, J., Glinsky, V.V., Landon, L.A., Matthews, L., Deutscher, S.L., Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion (2005) Carcinogenesis, 26, pp. 309-318

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------